SFX by Ex Libris Inc.

Title:	Effect of lipase conditioning on its activity in organic media
Source:	Applied Microbiology and Biotechnology [0175-7598] Monot, Frderic yr:1993

Basic

Full text

Full text available via SpringerLINK Contemporary 1997-Present

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Adams, G D D. "Optimizing the lyophilization cycle and the consequences of collapse on the pharmaceutical acceptability of Erwinia L-asparaginase." Journal of pharmaceutical sciences 85.12 (1997): 1301-5.
description	2.	Joel, S. "The clinical pharmacology of etoposide: An update." Cancer Treatment Reviews 22.3 (1996): 179-221.
description	3.	Maa, Y F F. "Effect of mannitol crystallization on the stability and aerosol performance of a spray-dried pharmaceutical protein, recombinant humanized anti-IgE monoclonal antibody." Journal of pharmaceutical sciences 87.11 (1998): 1406-11.
description	4.	Kravchenko, O. "Three-dimensional structures of L-asparaginase from Erwinia carotovora complexed with aspartate and glutamate." Acta crystallographica. Section D, Biological crystallography 64.Pt 3 (2008): 248-256.
description	5.	Nelson, C. "Freezing temperatures in the vaccine cold chain: a systematic literature review." Vaccine 25.20 (2007): 3980-6.
description	6.	Royall, P G G. "Characterisation of the glass transition of an amorphous drug using modulated DSC." Pharmaceutical research 15.7 (1998): 1117-21.
description	7.	Andya, James D. D. "The effect of formulation excipients on protein stability and aerosol performance of spray-dried powders of a recombinant humanized anti-IgE monoclonal antibody." Pharmaceutical Research 16.3 (1999): 350-358.
description	8.	Vrat, P. "Literature review analytics (LRA) on sustainable cold-chain for perishable food products: research trends and future directions." Opsearch. 55.3: 1-27.
description	9.	Techathawat, S. "Exposure to heat and freezing in the vaccine cold chain in Thailand." Vaccine 25.7 (2007): 1328-1333.
description	10.	STECKEL, J. "KINETIC-PROPERTIES AND INHIBITION OF ACINETOBACTER-GLUTAMINASE-ASPARAGINASE." Biochemical pharmacology 32.6 (1983): 971-977.
description	11.	EL, M. "Colon cancer information as a source of exercise motivation for relatives of patients with colon cancer." Psychology, health & medicine 15.6 (2010): 729-741.
description	12.	Stewart, C F F. "Use of etoposide in patients with organ dysfunction: pharmacokinetic and pharmacodynamic considerations." Cancer Chemotherapy and Pharmacology 34 Suppl.S1 (1994): 76-83.
description	13.	Lippard, Stephen J. "Zinc-bound thiolate-disulfide exchange: a strategy for inhibiting metallo-beta-lactamases." Inorganic chemistry (2003): 1604-1615.
description	14.	Molina, P. "Cold chain maintenance in vaccines: a systematic review." Gaceta sanitaria 21.4 (2007): 343-348.
description	15.	Derendorf, H. "Modeling of pharmacokinetic/pharmacodynamic (PK/PD) relationships: Concepts and perspectives." Pharmaceutical Research 16.2 (1999): 176-185.
description	16.	Lal, P. "Edible vaccines: current status and future." Indian journal of medical microbiology 25.2 (2007): 93-102.
description	17.	SLEVIN, M. "THE CLINICAL-PHARMACOLOGY OF ETOPOSIDE." Cancer 67.1 (1991): 319-329.
description	18.	Buckley, CP P. "Glass-rubber constitutive model for amorphous polymers near the glass transition." Polymer 36.17 (1995): 3301-3312.
description	19.	Bakshi, M. "Development of validated stability-indicating assay methods--critical review." Journal of pharmaceutical and biomedical analysis 28.6 (2002): 1011-40.
description	20.	Vanbever, R. "Influence of formulation excipients and physical characteristics of inhalation dry powders on their aerosolization performance." Journal of Controlled Release 70.3 (2001): 329-39.